CCWM
BSX icon

Cassaday & Co Wealth Management’s Boston Scientific BSX Stock Holding History

Cassaday & Co Wealth Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.7K Sell
438
-77
-15% -$4.18K ﹤0.01% 783
2026
Q1 		$32.3K Buy
+515
New +$41.2K ﹤0.01% 701

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cassaday & Co Wealth Management's BSX Position: Q2 2026 in Review

Cassaday & Co Wealth Management reduced its Boston Scientific (BSX) stake by 15% in Q2 2026, selling an estimated $4.18K and leaving 438 shares worth $18.7K. The position accounts for ﹤0.01% of the portfolio, ranked #783.

Cassaday & Co Wealth Management first reported a position in BSX in Q1 2026 and has held it in 2 quarters since. The position peaked at $32.3K in Q1 2026. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Cassaday & Co Wealth Management held 438 shares of Boston Scientific worth $18.7K as of Q2 2026.
  • Cassaday & Co Wealth Management sold 77 Boston Scientific shares in Q2 2026, an estimated $4.18K.
  • Boston Scientific made up ﹤0.01% of Cassaday & Co Wealth Management's portfolio in Q2 2026, its #783 holding.
  • Cassaday & Co Wealth Management first reported a position in Boston Scientific in Q1 2026 and has held it in 2 quarters since.
  • Cassaday & Co Wealth Management's Boston Scientific position peaked at $32.3K in Q1 2026.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.